3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
4
Carcinoma, Renal Cell
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Kidney Neoplasms
3
Pancreatic Neoplasms
2
Multiple Myeloma
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia
2
Warts
1
Small Cell Lung Carcinoma
1
Recurrence
1
Papilloma
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Lung Neoplasms
1
HIV Infections
1
Colorectal Neoplasms
1
Acquired Immunodeficiency Syndrome
1
Interventions
Radiotherapy
11
Cisplatin
10
Paclitaxel
9
pembrolizumab
7
Fluorouracil
7
Oxaliplatin
6
Irinotecan
6
tislelizumab
5
Cetuximab
5
Docetaxel
4
Radiation
3
Nivolumab
3
Leucovorin
3
Carboplatin
3
Capecitabine
3
Neoadjuvant Therapy
2
Immunohistochemistry
2
Biopsy
2
10-propargyl-10-deazaaminopterin
2
tremelimumab
1
sitravatinib
1
sintilimab
1
regorafenib
1
pegylated granulocyte colony-stimulating factor, human
1
pegfilgrastim
1
oblimersen
1
durvalumab
1
cixutumumab
1
adavosertib
1
Taxes
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Esophageal Squamous Cell Carcinoma
×
Interferon-alpha
×
Clear all
No trials found.